%D9%83%D8%A7%D8%A8%D8%B1%D8%AC%D9%88%D9%84%D9%8A%D9%86%DA%A9%D8%A7%D8%A8%D8%B1%D9%82%D9%88%D9%84%DB%8C%D9%86CabergolinCabergolinCabergolineCabergolina%DA%A9%D8%A7%D8%A8%D8%B1%DA%AF%D9%88%D9%84%DB%8C%D9%86CabergolineCabergolinaKabergolinKabergolinaCabergolinaKabergolinKabergolinKabergolin%D0%9A%D0%B0%D0%B1%D0%B5%D1%80%D0%B3%D0%BE%D0%BB%D1%96%D0%BDQ423308
about
5-hydroxytryptamine receptor 2ADopamine receptor D25-hydroxytryptamine receptor 2CDopamine receptor D1Dopamine receptor D35-hydroxytryptamine receptor 1A5-hydroxytryptamine receptor 1DDopamine receptor D5Adrenoceptor alpha 2B5-hydroxytryptamine receptor 1BDopamine receptor D45-hydroxytryptamine receptor 2BAdrenoceptor alpha 1AAdrenoceptor alpha 2CAdrenoceptor alpha 2A
P129
The Influence of Dopamine Agonist Cabergoline on Oocyte MaturationCabergoline Effect on Blood Sugar in Type 2 DiabeticsCabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant ProlactinomasCo-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM PatientsCabergoline for the Treatment of Chronic Pain Due to EndometriosisStudy of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's DiseaseNurse's Role in the Management of Hyperprolactinemia
P4844
Cabergoline for preventing ovarian hyperstimulation syndromeCabergoline as treatment of ovarian hyperstimulation syndrome: a review.Cabergoline use and risk of fibrosis and insufficiency of cardiac valves. Meta-analysis of observational studies.Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas.Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneasThe Mechanism and Pathways of Dopamine and Dopamine Agonists in ProlactinomasCan a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
P921
Q1949517-F92A8556-E413-40C5-B048-9B8D343C5A65Q2034004-E7F3B799-8182-4AF6-B75F-92E9AF949F27Q21108118-71DA54E1-1F12-46FD-A8E6-5999E8E9CA52Q21110867-1DE4DF9F-E247-4364-87A6-F404F75C4C19Q21110872-F8108286-8984-441A-BC20-1575B4B57CDDQ21115043-676978C4-0C8F-4AAF-BB0D-9205F7F7A99CQ21115046-5475A564-3025-45AE-86F3-184057BE73CEQ21131500-579422ED-C93A-4BEA-BA07-2B6073810065Q21141045-F185B1F4-345F-4DB3-B032-AA32CD776DCCQ288797-489F8F3E-CAC0-447D-9695-50DD217520EEQ308856-795286AA-84C3-46EE-8201-F13EA388D583Q4639596-97F2CF03-3FDE-455D-84E1-C0470CB49DC2Q4734884-FD8DFE10-18F1-4681-851B-C7A6B05D3814Q4734891-FC62F139-562E-4DB9-99AF-14E625B31E8CQ4734892-6E34FA6F-A676-46E5-B0A7-8497DB5B769C
P129
Q61939376-46DB7A9F-B79D-4AC9-A2A6-48D2945FCD38Q61965772-848AF13E-3EE4-4059-A440-341326BD90A1Q63401862-56F931B9-AEC5-4F88-8CC5-CD5D7FD275DEQ63571160-80050488-C310-4C1F-B876-69C9CA210D63Q63572107-12C1ECDF-BAFD-4FD4-969E-E99142E8CCD8Q63590869-A76895E8-2D89-4619-A4F5-38818599E505Q86303967-C8E55F7D-7862-4957-9F71-6FA356379AED
P4844
Q24203638-9378C358-7EC2-4967-94AD-31E6E299730DQ38056538-D5C5E7D4-E013-4800-AB12-0BC1B424A861Q38112589-DF5E328C-93E3-48EF-A993-403DE3A64F84Q43586476-85AFA2D1-85A4-43B7-82D1-65C4571A0EEAQ44054556-1E124EC2-25B9-42C6-8145-FFA8F0B4A2DBQ61810063-CFE720BD-AE53-4778-A820-7BD2E1E53700Q61811625-848AF203-0AC2-4024-B3E4-0DD77DCB497CQ64071158-11C7940E-AB57-4052-BA0F-9B528142E66A
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Cabergolin
@de
Cabergoline
@nl
Kabergolin
@nb
Kabergolin
@sh
Kabergolin
@sr-el
Kabergolin
@sv
Kabergolina
@pl
cabergolin
@cy
cabergolina
@es
cabergolina
@it
type
label
Cabergolin
@de
Cabergoline
@nl
Kabergolin
@nb
Kabergolin
@sh
Kabergolin
@sr-el
Kabergolin
@sv
Kabergolina
@pl
cabergolin
@cy
cabergolina
@es
cabergolina
@it
altLabel
(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
@en
(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
@cy
(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
@en
(8beta)-N-[3-(dimethylamino)Pr ...... openyl)-ergoline-8-carboxamide
@en
(8beta)-N-[3-(dimethylamino)pr ...... openyl)-ergoline-8-carboxamide
@cy
(8beta)-N-[3-(dimethylamino)pr ...... openyl)-ergoline-8-carboxamide
@en
1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
@en
1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
@cy
1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
@en
1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea
@en
prefLabel
Cabergolin
@de
Cabergoline
@nl
Kabergolin
@nb
Kabergolin
@sh
Kabergolin
@sr-el
Kabergolin
@sv
Kabergolina
@pl
cabergolin
@cy
cabergolina
@es
cabergolina
@it